These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20621485)

  • 1. Pharmacophore identification, synthesis, and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonists.
    Dong X; Wang L; Huang X; Liu T; Wei E; Du L; Yang B; Hu Y
    Bioorg Med Chem; 2010 Aug; 18(15):5519-27. PubMed ID: 20621485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists.
    Zwaagstra ME; Timmerman H; Tamura M; Tohma T; Wada Y; Onogi K; Zhang MQ
    J Med Chem; 1997 Mar; 40(7):1075-89. PubMed ID: 9089329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
    Bonjoch J; Diaba F; Pagès L; Pérez D; Soca L; Miralpeix M; Vilella D; Anton P; Puig C
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4299-302. PubMed ID: 19505824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel acyl coenzyme a: cholesterol acyltransferase inhibitors: pharmacophore-based virtual screening, synthesis and pharmacology.
    Chhabria MT; Brahmkshatriya PS; Mahajan BM; Darji UB; Shah GB
    Chem Biol Drug Des; 2012 Jul; 80(1):106-13. PubMed ID: 22429570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
    Li MY; Tsai KC; Xia L
    Bioorg Med Chem Lett; 2005 Feb; 15(3):657-64. PubMed ID: 15664832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.
    Aparoy P; Kumar Reddy K; Kalangi SK; Chandramohan Reddy T; Reddanna P
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1013-8. PubMed ID: 20045317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.
    Dong X; Zhou X; Jing H; Chen J; Liu T; Yang B; He Q; Hu Y
    Eur J Med Chem; 2011 Dec; 46(12):5949-58. PubMed ID: 22027102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
    Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY
    J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and screening of a combinatorial library of naphthalene substituted chalcones: inhibitors of leukotriene B4.
    Deshpande AM; Argade NP; Natu AA; Eckman J
    Bioorg Med Chem; 1999 Jun; 7(6):1237-40. PubMed ID: 10428396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
    Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
    Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of benzo[b]furans having five-membered heterocycles at the 2-position and 2-(4-Alkylcarbamoylbuta-1,3-dienyl)benzo[b]furans, and their cysteinyl leukotriene receptor (cysLT1, cysLT2) inhibitory activity.
    Akai Y; Tabuchi Y; Ando K; Ito A; Sakata Y; Kawasaki I; Ohishi T; Yamashita M; Ohta S; Nishide K; Ohishi Y
    Chem Pharm Bull (Tokyo); 2012; 60(11):1461-7. PubMed ID: 23124570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design.
    Ye Y; Liao Q; Wei J; Gao Q
    Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a three-dimensional CysLT1 (LTD4) antagonist model with an incorporated amino acid residue from the receptor.
    Zwaagstra ME; Schoenmakers SH; Nederkoorn PH; Gelens E; Timmerman H; Zhang MQ
    J Med Chem; 1998 Apr; 41(9):1439-45. PubMed ID: 9554877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure-activity relationship studies of chalcones as SRS-A receptor antagonists].
    He KQ; Cheng GF; Xi FD; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1996; 31(11):878-80. PubMed ID: 9863261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
    Deng J; Sanchez T; Al-Mawsawi LQ; Dayam R; Yunes RA; Garofalo A; Bolger MB; Neamati N
    Bioorg Med Chem; 2007 Jul; 15(14):4985-5002. PubMed ID: 17502148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
    Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Krovat EM; Langer T
    J Med Chem; 2003 Feb; 46(5):716-26. PubMed ID: 12593652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
    Cai BL; Huang XQ; Dong XW; Fang SH; Lu YB; Zhang WP; Hu YZ; Shen JG; Wei EQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):598-604. PubMed ID: 20014485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 1,3-diphenyl-2-propen-1-one derivatives and evaluation of their biological activities.
    Jang S; Jung JC; Oh S
    Bioorg Med Chem; 2007 Jun; 15(12):4098-105. PubMed ID: 17448664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new chalcone derivatives containing acridinyl moiety with potential antimalarial activity.
    Tomar V; Bhattacharjee G; Kamaluddin ; Rajakumar S; Srivastava K; Puri SK
    Eur J Med Chem; 2010 Feb; 45(2):745-51. PubMed ID: 20022412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.